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Vibrio cholerae strains of serotypes O1 and O139 are the only
causes of cholera. However, other serotypes ofV. cholerae, so-
called non-O1, non-O139 serotypes, are increasingly being
associated with human disease, in particular diarrhoea [1^5].
Non-O1, non-O139 strains ofV. cholerae have also been isolated
from blood, from wound and ear infections and from other
clinical sites; such infections comprise up to 50% of the
reported non-O1, non-O139 infections in theUSA [6]. Extra-
intestinal invasive infections have also been described from
southern Europe [7,8]. Isolation of V. cholerae non-O1, non-
O139 fromwound and ear infections havewith few exceptions
all been associated with water exposure, mainly to seawater
[6,9]. However, little is known about the occurence and char-
acteristics ofV. cholerae non-O1, non-O139 infections in tem-
perate areas in Europe, particularly northern Europe. Cases of
non-O1, non-O139 gastrointestinal infections in the USA
seem to occur in the late summer and early fall when water
temperatures and the numbers of non-O1, non-O139 strains
are high in the aquatic environment (water and oysters) [10]. A
similar positive correlation between water temperatures and
the incidence of extra-intestinal non-O1, non-O139V. cholerae
infections would be expected. In the present study, we report
the clinical manifestations and strain characteristics of eight
extra-intestinal V. cholerae non-O1, non-O139 infections
acquired between1994 and1998 in Denmark.
The clinical strains examined are listed inTable1.The strains
were obtained from cases of V. cholerae non-O1, non-O139
infections which were sent to Statens Serum Institut in
Copenhagen for ¢nal identi¢cation or veri¢cation. Strains
were identi¢ed asV. cholerae using criteria described in theMan-
ual of ClinicalMicrobiology [11] andwere tested for agglutination
in polyvalent V. cholerae O1 antiserum (Difco, Detroit, MI,
USA). Each strainwas further examined serologically by DrT.
Shimada at the National Institute of Infectious Diseases,
Tokyo, by the slide agglutination test and designated accord-
ing to an extended serotyping system (O1 to O140) estab-
lished by Shimada et al. [12]. Strains were examined by the
colony hybridization technique for DNA sequences encoding
a heat-stable enterotoxin (NAG-ST) and cholera toxin (CT)
using alkaline phosphatase-labeled oligonucleotide probes
consisting of 16 and 23 base pairs, respectively [13^15]. NAG-
STand CTare well recognized virulence genes amongV. cho-
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Table 1 Summary of clinical data of eight patients from whom extra-intestinal Vibrio cholerae non-O1, non-O139 was isolated in Denmark
between 1994 and 1998
Case no. Date of exposure Age/sex Exposure to water Clinical presentation Pure culture O-serotypea
1 July 1994 82/F Unknown Septicemia Yes ± e
2 July 1994 65/M Seawater Ulcus cruris Unknown O10
3 August 1994 14/M Seawater Otitis media acuta Nob O19
4 August 1994 42/M Seawater Otitis media chronica Yes O52
5 August 1994 10/M Seawater Otitis media serosa, tubulation Yes O10
6 April 1996 10/M Fresh water/swimming pool Otitis externa Noc O15
7 September 1997 13/M Fresh water Otitis externa, cholesteatoma Yes O26
8 March 1998 36/M Unknown Otitis externa Nod O19
aO-serotype according to the extended serotyping scheme by Shimada et al. [12]. bShewanella putrefaciens/ algae also isolated from ear.
cStaphylococcus aureus also isolated from ear. dPseudomonas spp. also isolated from ear. eStrain not available.
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lerae non-O1, non-O139 strains associated with gastrointest-
inal diseases [16].
Susceptibilityof theV. cholerae isolates to penicillin, ampicil-
lin, cefuroxime, ceftriaxone, gentamicin, cipro£oxacin, tetra-
cycline and chloramphenicol were determined by the Epsilon
test (E test) method (AB Biodisk, Sweden) according to the
manufacturer's instructions. Tablet di¡usion was done with
Neo-Sensitabs (Rosco, Taastrup, Denmark) containing tri-
methoprim-sulfamethoxazole, polymyxin E and the vibrio-
static agent O/129 (150 mg). Repeated plasmid analyses were
done using appropriate controls as described previously
[17,18].
PFGE typing using the restriction enzymeNotI was carried
out by using a modi¢ed contour-clamped homogeneous elec-
tric ¢eld (CHEF) system (Pulsaphor Plus, Pharmacia LKB,
Sweden) as described byDalsgaard et al. [19].
A summary of important clinical data of the eight cases of
extra-intestinal cases ofV. cholerae non-O1, non-O139 is pre-
sented inTable1.The ¢rst patient (case no. 1) was a previously
healthy woman who presented with primary bacteremia
without a known bacteriological or clinical focus, including
no preceding diarrhea. Cultures of stool samples were repeat-
edly negative forV. cholerae.The patient was treatedwith ampi-
cillin and gentamicinwith good e¡ect.This strain ofV. cholerae
was unfortunately lost and thus not available for further char-
acterization. The severity of the leg ulcer of the 65-year-old
male (case no. 2) necessitated debridement and skin transplan-
tation. The remaining six cases all involved ear infections, of
which three (case nos 4, 5 and 7) were acute exacerbations on
the basis of chronic conditions, involving tubulation and cho-
lesteatoma. Of the remaining three episodes, one patient (case
no. 3) had never had previous ear problems, another (case no.
6) had been tubulated as a young child, but had been without
ear problems for the last 4 years, and there was no history on
the last patient (case no. 8). In the patient presenting as acute
otitis media (case no. 3), paracentesis was performed. The
other ¢ve ear-patients were treated with hydrocortisone^
polymyxin^tetracycline ear drops with apparent good e¡ect.
In one case (case no. 7), however, a cholesteatoma was diag-
nosed, necessitating debridement and tympanoplasty.
The seven clinical strains available for characterization
showed the typical biochemical characteristics of V. cholerae,
including the ability to produce lysine decarboxylase, a posi-
tive ONPG test, sensivitity to O/129 and growth in amedium
without NaCl [11]. None of the strains agglutinated with the
polyvalent O1 antiserum. Further serotyping revealed that
two strains belonged to serotypes O10 and O19 each, while
single strains belonged to serotypes O15, O26 and O52 (Table
1). The cases yielding identical serotypes did not appear to be
epidemiologically related. None of the seven strains contained
plasmids in repeated testing, nor did they contain NAG-ST
and CTgenes, as shown in the colony hybridization studies.
Genotyping of the seven strains by PFGE revealed very dif-
ferent types di¡ering from each other by more than seven
fragments, showing that the strains were not genotypically
related (results not shown).
Overall, little di¡erence was found among the V. cholerae
examined in their susceptibilities towards any of the antibio-
tics tested. According to the NCCLS performance standards,
minimum inhibitory concentration (MIC) values, which are
shown in brackets, all seven strains were found by the E test
method to be susceptible to ampicillin (R 8mg/L), cefurox-
ime (R 8mg/L), ceftriaxone (R 8mg/L), gentamicin (R4
mg/L), cipro£oxacin (R1mg/L), tetracycline (R4mg/L)
and chloramphenicol (R 8mg/L) , but resistant to penicillin
(R 0.12mg/L) [20]. Similar results were obtained by the
tablet di¡usion test, which also demonstrated susceptibility to
O/129 and trimethoprim^sulfamethoxazole and resistance to
polymyxin Ewith the exception of one strain.
This study ofV. cholerae non-O1, non-O139 isolated in Den-
mark between 1994 and 1998 presents clinical and bacteriolo-
gical characterization of extra-intestinal V. cholerae infections
acquired in Scandinavia. To the best of our knowledge, these
eight patients comprise all of the known cases of extra-intest-
inalV. cholerae infections in Denmark during this period. Pre-
vious studies have mainly described cases of extra-intestinal
infections from subtropical and tropical areas, in particular in
the USA [9]. In the present study, V. cholerae non-O1, non-
O139 was isolated in pure culture from four patients, whereas
specimens from the cases of three patients gave growth of
other external otitis pathogens (Table1). Thus, our ¢ndings
suggest that the isolatedV. cholerae strains were associated with
the clinical manifestations presented. However, it should be
noted that virulence factors enablingV. cholerae to cause extra-
intestinal infections have not been demonstrated to date. Our
¢nding that none of the strains contained the enterotoxin
genes NAG-ST and CT suggest, as expected, that these genes
are not involved in extra-intestinal infections.
Five patients, of whom four had a history of exposure to
seawater, obtained their infections in July and August 1994. It
has previously been reported that during this summer, which
was the hottest recorded at the Danish Meteorological Insti-
tute with bathing water temperatures above 20 C for several
weeks, 11 patients acquired wound infections withV. vulni¢cus
[21]. A later environmental study ofVibro vulni¢cus in Danish
costal waters showed a positive correlation between the water
temperature and the numbers ofV. vulni¢cus [22]. These ¢nd-
ings are corroborated by an earlier Danish report of an increase
in the number of extra-intestinal infections caused byV. para-
haemolyticus and V. alginolyticus during warm summers from
1987 to 1992 [23]. As the ecology ofV. cholerae non-O1, non-
O139 resembles that of other human pathogenic vibrios in sev-
eral aspects, it is likely that relatively higher numbers of non-
O1, non-O139 in Danish coastal waters together with an
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increased bathing activty in 1994 were associated with the iso-
lation ofV. cholerae from patients, mainly with ear infections.
In contrast to other halophilic human pathogenicVibrio spp.,V.
cholerae can survive and multiply in fresh water. Thus, extra-
intestinal infections with V. cholerae may occur in patients
exposed to fresh water, as was illustrated by the isolation ofV.
cholerae from two patients with histories of exposure appar-
ently only to fresh water. One of these cases had repeated
exposure to water in swimming pools prior to the develop-
ment of otitis externa.
The incidence of V. cholerae non-O1, non-O139 infections
in the study period was most probably higher than reported,
since less severe cases of ear and wound infections presumably
would not have been presented to physicians. Although ear
and wound specimens are not cultured on media speci¢c for
Vibrio spp. (thiosulfate^citrate^bile salt^sucrose (TCBS)
agar) in clinical microbiology laboratories in Denmark,Vibrio
species are expected to be recovered, as they readily grow on
blood agar plates routinely used by the laboratories. Our study
shows that physicians in temperate countries should be aware
of the possibility ofV. cholerae non-O1, non-O139 extra-intest-
inal infections, especially in patients seen during warm sum-
mers when water temperatures and recreational activities in
water are high.
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